948 / 1544
ESTRO IMRT Course May 2013
Canadian H&N IMRT-Review and Consensus
“The case for IMRT in head and neck cancer can be broadly
outlined as follows:
1) The data identified in this review, as well as the earlier
historical data described in the Introduction, support
the contention that IMRT is, at worst, not inferior to
two-dimensional CRT with respect to disease control.
2) The data identified in this review, as well as the earlier
historical data, support the contention that with IMRT,
there are clinically relevant and statistically significant
differences in adverse event rates and quality of life
compared with two-dimensional CRT.”
O‘Sullivan et al., Clin Oncol, 2012